C-mer Medical logo

C-mer Medical(SEHK) 3309

Market CapHK$951.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-83%
5 Year-90%
1 Year-59%
1 Month-6%
HK$0.80
+0.00%
+0.00Today
C-mer Medical last closing stock price
MetricPriceDate
Last closeHKD 0.802026-10-14
C-mer Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.27%HKD 0.792026-10-07
1 month-6.43%HKD 0.862026-09-14
3 month-18.37%HKD 0.982026-07-16
Year to date-53.49%HKD 1.722025-12-31
1 year-58.55%HKD 1.932025-10-14
3 year-79.85%HKD 3.972023-10-13
5 year-90.48%HKD 8.402021-10-15
Since inception-83.48%HKD 4.842018-01-15

C-mer Medical Financials at a Glance

Market Cap

HK$951.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$3.96B

Net Income (TTM)

-HK$15.54M

EPS (TTM)

HK$0.08

P/E Ratio

9.48

Dividend

HK$0.02

Beta (Volatility)

0.05 (Low)

Price

HK$0.80

Volume

282,000

Open

HK$0.80

Previous Close

HK$0.80

Daily Range

HK$0.79 - HK$0.81

52-Week Range

HK$0.73 - HK$1.96

Estimated Earnings Date

Mar 30, 2027

3309 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About C-mer Medical

C-MER Medical Holdings Limited specializes in offering medical treatments and therapeutic services for various eye conditions. Established in 2016, the company operates primarily in ophthalmological services and the retail of vision-enhancing products, with its headquarters located in Hong Kong.

Products and Services
  • Ophthalmological services for eye conditions
  • Retail of vision-enhancing products
  • Comprehensive therapeutic services
Growth Outlook
  • Revenue increased to HKD 1.02 billion in Q2 2026
  • Gross profit margin improved to 31.6% in the latest quarter
  • Strong demand for eye care services supports future growth
Financial Highlights
  • Net income of HKD 50.02 million reported for Q2 2026
  • Trailing twelve months (TTM) P/E ratio stands at 9.26
  • Dividend yield of 3.85% reflects shareholder returns
C-MER Medical Holdings Limited has demonstrated a solid performance in the healthcare sector, particularly in eye care services. The recent quarterly results indicate a significant revenue increase, showcasing the company's ability to capitalize on the growing demand for ophthalmological treatments. The improvement in gross profit margin further highlights operational efficiency and effective cost management. The company's TTM P/E ratio of 9.26 suggests that it is trading at a reasonable valuation compared to industry peers, potentially offering an attractive investment opportunity. Additionally, the dividend yield of 3.85% provides a steady return for investors, reflecting the company's commitment to shareholder value. Overall, C-MER Medical Holdings Limited is well-positioned for continued growth in the healthcare sector, driven by its specialized services and expanding market presence.
AI Generated • Sep 30, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,200

CEO

Xiao Ting Li

Website

www.cmereye.com

Headquarters

Hong Kong, HK

3309 Financials

Key Financial Metrics (TTM)

Gross Margin

31.24%

Operating Margin

8.57%

Net Income Margin

4.96%

Return on Equity

5.57%

Return on Capital

7.61%

Return on Assets

3.51%

Earnings Yield

10.55%

Dividend Yield

2.50%

Payout Ratio

0.00%

Stock Overview

Market Cap

HK$951.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.19B

Volume

282.00K

Avg. Volume

386.72K

Financials (TTM)

Gross Profit

HK$1.23B

Operating Income

HK$115.34M

EBITDA

HK$699.60M

Operating Cash Flow

HK$662.85M

Capital Expenditure

-HK$195.96M

Free Cash Flow

HK$466.89M

Cash & ST Invst.

HK$563.37M

Total Debt

HK$433.61M

C-mer Medical Performance Analysis

C-mer Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 1,731,903,00055.7%
20232023-12-31HKD 1,923,964,00011.1%
20242024-12-31HKD 1,913,162,000-0.6%
20252025-12-31HKD 1,946,712,0001.8%
C-mer Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-317.4%
Q22025-06-30-4.7%
Q42025-12-316.1%
Q22026-06-302.2%
C-mer Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD -0.02N/A
20232023-12-31HKD 0.05N/A
20242024-12-31HKD -0.11N/A
20252025-12-31HKD 0.08N/A
C-mer Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-624.2%
Q22025-06-30131.6%
Q42025-12-312.4%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$1.02B

+11.0%

Gross Profit

HK$323.36M

+11.8%

Gross Margin

31.56%

N/A

Market Cap

HK$951.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$432.38K

N/A

Employees

2,200

N/A

Net Income

HK$50.02M

+62.6%

EBITDA

HK$198.32M

+10.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$563.37M

+10.0%

Total Debt

HK$433.61M

+8.1%

Accounts Receivable

HK$60.72M

+14.7%

Inventory

HK$55.38M

+14.4%

Long Term Debt

HK$260.93M

-10.0%

Short Term Debt

HK$172.68M

+55.2%

Return on Assets

3.51%

N/A

Return on Invested Capital

7.45%

N/A

Free Cash Flow

HK$177.46M

+245.3%

Operating Cash Flow

HK$221.32M

+63.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,803.85-0.00%
^DJIDJI
$51,687.96-0.00%
^IXICNASDAQ
$27,201.84-0.00%
BTCBitcoin
$83,069.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$50.97-5.55%
CRWVCoreWeave
$65.12-16.32%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$41.84+11.81%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$112.65-11.70%

Questions About 3309

What is the current price of C-mer Medical?

C-mer Medical is trading at HK$0.80 per share.

What is the 52-week range for C-mer Medical?

Over the past 52 weeks, C-mer Medical has traded between HK$0.73 and HK$1.96.

How much debt does C-mer Medical have?

As of the most recent reporting period, C-mer Medical reported total debt of HK$426.78M.

How much cash does C-mer Medical have on hand?

C-mer Medical reported HK$347.87M in cash and cash equivalents in its most recent financial results.

What is C-mer Medical’s dividend yield?

C-mer Medical currently has a dividend yield of 2.50%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services